JESSICA SHAW: Open Payments
NPI 1417969429 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 11 payments from 5 companies in 2025. Trend: 2023 $585 · 2024 $846 · 2025 $408
Food & beverage: $318Education: $90
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 5 | $195 |
| ABBVIE INC. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $31 |
| Molnlycke Health Care US, LLC | 1 | $28 |
Products named: Yescarta, IMBRUVICA, DUPIXENT, Xospata, Mepilex Border Post-Op Ag, EPKINLY.
Industry payments across TX — which companies pay providers there.
